HIT 8-K
Health In Tech, Inc. (HIT)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
Current Report
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
(Exact name of registrant as specified in its charter)
| (State or other jurisdiction of incorporation) |
(Commission File Number) | (IRS Employer Identification No.) |
| (Address of principal executive offices) | (Zip Code) |
Registrant’s
telephone number, including area code: (
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||
| The (Nasdaq Capital Market) |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging
growth company
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item 7.01. Regulation FD Disclosure.
On August 13, 2026, Health In Tech, Inc., a Nevada corporation (the “Company”), prepared an investor presentation that officers and other representatives of the Company intend to present at conferences and meetings. A copy of the investor presentation is furnished as Exhibit 99.1 of this Current Report on Form 8-K. The information set forth in this Item 7.01 of this Current Report on Form 8-K and in the attached Exhibit 99.1 is deemed to be “furnished” and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section. The information set forth in Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed incorporated by reference into any filing under the Exchange Act or the Securities Act of 1933, as amended, regardless of any general incorporation language in such filing.
Forward-Looking Statements
Certain statements in this Current Report on Form 8-K or in the accompanying exhibits are forward-looking statements for purposes of the safe harbor provisions under the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements may include estimates or expectations about Health In Tech’s possible or assumed operational results, financial condition, business strategies and plans, market opportunities, competitive position, industry environment, and potential growth opportunities. In some cases, forward-looking statements can be identified by terms such as “may,” “will,” “should,” “design,” “target,” “aim,” “hope,” “expect,” “could,” “intend,” “plan,” “anticipate,” “estimate,” “believe,” “continue,” “predict,” “project,” “potential,” “goal,” or other words that convey the uncertainty of future events or outcomes. These statements relate to future events or to Health In Tech’s future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause Health In Tech’s actual results, levels of activity, performance, or achievements to be different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond Health In Tech’s control and which could, and likely will, affect actual results, levels of activity, performance or achievements. Some of the risks and uncertainties, although not all risks and uncertainties, that could cause the Company’s actual results to differ materially from those presented in its forward-looking statements are set forth in the “Risk Factors” section in the Company’s Annual Report on Form 10-K, its Quarterly Reports on Form 10-Q, and all of its other filings with the U.S. Securities and Exchange Commission, as such risks, uncertainties and other important factors may be updated from time to time in the Company’s subsequent reports. Any forward-looking statement reflects Health In Tech’s current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to Health In Tech’s operations, results of operations, growth strategy and liquidity. Health In Tech undertakes no obligation to update any forward-looking statements, except as required by law.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits:
| Exhibit No. | Description | |
| 99.1 | Investor Presentation. | |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
1
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Dated: August 13, 2026 | ||
| HEALTH IN TECH, INC. | ||
| By: | /s/ Tim Johnson | |
| Name: | Tim Johnson | |
| Title: | Chief Executive Officer | |
2
Exhibit 99.1
An AI-Powered Marketplace Platform Helping SMBs Access Better Self-Funded Health Plans
Disclaimer & Safe Harbor This presentation has been prepared by the Health In Tech, Inc. (the "Company," "Health In Tech," "HIT," "we," "our," or "us") solely for informational purposes. The information included herein in this presentation has not been independently verified. No representations, warranties or undertakings, express or implied, are made by the Company or any of its affiliates, advisers or representatives as to, and no reliance should be placed upon, the accuracy, fairness, completeness or correctness of the information or opinions presented or contained in this presentation. By viewing or accessing the information contained in this presentation, you acknowledge and agree that to the fullest extent permitted by law, none of the Company or any of its affiliates, advisers or representatives accept any responsibility whatsoever (in negligence or otherwise) for any loss howsoever arising from any information presented or contained in this presentation or otherwise arising in connection with the presentation. Industry and market data used in this presentation have been obtained from third -party industry publications and sources as well as from research reports prepared for other purposes. The Company has not independently verified the data obtained from the sources and cannot assure you of the data's accuracy or completeness. The information presented or contained in this presentation is subject to change without notice and its accuracy is not guaranteed. None of the Company or any of its affiliates, advisers or representatives make any undertaking to update any such information subsequent to the date hereof. This presentation should not be construed as legal, tax, investment or other advice. This presentation does not constitute or form part of, and should not be construed as, an offer to sell or issue or the solicitation of an offer to buy or acquire securities of the Company, nor shall there be any sale of securities in any state or other jurisdiction to any person or entity to which it is unlawful to make such offer, solicitation or sale in such state or jurisdiction. No part of this presentation shall form the basis of or be relied upon in connection with any contract or commitment whatsoever. Specifically, these materials do not constitute a "prospectus" within the meaning of the U.S. Securities Act of 1933, as amended, and the regulations enacted thereunder. This presentation does not contain all relevant information relating to the Company or its securities, particularly with respect to the risks and special considerations involved with an investment in the securities of the Company. In evaluating its business, the Company uses certain non-GAAP measures as supplemental measures to review and assess its operating and financial performance. These non-GAAP financial measures have limitations as analytical tools, and when assessing the Company's operating and financial performances, investors should not consider them in isolation, or as a substitute for any consolidated statement of operations data prepared in accordance with U.S. GAAP. Reconciliation of any non-GAAP financial measures to their closest corresponding GAAP measures is provided in the Appendix to this presentation. This presentation contains "forward-looking statements" within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, including but not limited to, statements regarding possible or assumed operational results, financial condition and outlook, business strategies and plans, market trends and opportunities, competitive position, industry environment and potential growth opportunities of the Company. These forward-looking statements are based on current expectations, estimates, forecasts and projections. Words such as "expect," "anticipate," "should," "believe," "hope," "target," "project," "goals," "estimate," "potential," "predict," "may," "will," "might," "could," "intend," "shall" and variations of these terms and similar expressions that convey the uncertainty of future events or outcomes are intended to identify these forward-looking statements, although not all forward-looking statements contain these identifying words. Forward-looking statements are subject to a number of risks and uncertainties, many of which involve factors or circumstances that are beyond our control. Factors that could cause actual results to differ from those projected include, but are not limited to, the following: the Company's liquidity position and ability to access capital; the Company's ability to continue as a going concern; employee attrition and the Company's ability to retain senior management and other key personnel; the Company's ability to enhance its existing products and services; product and service quality issues; and market competition. Further information on these and other factors that could affect the Company's financial results is included in the reports on Form 10-K, Quarterly Reports on Form 10-Q and other periodic filings with the Securities and Exchange Commission from time to time. Because of the risks and uncertainties, the Company cautions you not to place undue reliance on these statements, which speak only as of the date of this presentation. There may be additional risks of which we are not presently aware or that we currently believe are immaterial which could have an adverse impact on our business. Except as expressly required by the federal securities laws, we undertake no obligation, and specifically disclaim any obligation, to release any revision to any forward-looking statements to reflect events or circumstances after the date of this presentation or to reflect the occurrence of unanticipated events. 2
Health In Tech – Disrupting Healthcare Insurance Market (1) Sources: Centers for Medicare & Medicaid Services 2024 Data and IBISWorld Assessment: Health & Medical Insurance in the US - Market Size (2004-2032), available, respectively, at: https://www.cms.gov/data-research/statistics-trends-and-reports/national-health-expenditure-data/historical & https://www.ibisworld.com/united-states/market-size/health-medical-insurance/1324/ (2) CAGR is calculated from 2022 to the Mid-Point of 2026 Revenue Guidance of $47.5M (3) This is not a projection or guarantee of future results but rather is solely the guidance the Company reiterated in connection with its second quarter 2026 earnings release. The Company's actual results may vary significantly from this range. (4) As of Market Close 8/12/2026 HIT Helps Small & Medium Size Businesses ("SMBs") Access Cheaper Healthcare Faster Through its Proprietary Product Suite Operates in Massive Under-Penetrated Market(1) Proven, Scalable, Profitable, High Growth Business Fee Driven Business with No Plan or Underwriting Risk Exposure Highly Aligned Executive Leadership with Significant Ownership Key Market Statistics(4) ~$67M Market Cap $1.02 Stock Price ~65.5M Shares Out. Nasdaq: HIT HQ: Stuart, FL 3 Revenue Revenue ($M's) (3) (3)
I Business Overview
Problem: Access to Self-Funded Healthcare Plans (1) KFF 2025 Employer Health Benefit Survey, "2025 Employer Health Benefits Survey - Summary of Findings." (2) Intercept Health October 2024, "The Hidden Cost of Fully Insured Plans: Why Self-Funding is Usually Better for Employers - intercept.health," 5 Businesses want the cost and flexibility benefits provided by Self-Funded Healthcare Plans ("SFPs") Health In Tech's AI-powered solutions remove barriers, enabling SMBs to benefit from SFPs Self-funded plans provide material benefits vs. fully insured plans. Complexity of successfully implementing self- funded plans has impacted market penetration, especially for small businesses with limited resources. Complexity of SFPs have made implementation unrealistic for many business 15 – 20% Self-Funded Plan Penetration %(1) Small Business 27% Large Business 80% Estimated Self-Funded Savings(2)
AI Powered Platform Enables Self-Funded Plan Penetration 6 Health In Tech makes self-funded health insurance more accessible by integrating health plan administration and stop loss underwriting into one unified platform
Tailored Coverage Starts with SMR: Intelligent Plan Design 7 P B M s B ro k er s T P A s H ea lt hc ar e N et w or k s Te le m ed C o m p a ni e s M e di c al M G M T C o m p a ni es C ar ri er s Plan Design & Customization Underwriting & Risk Assessment Provider Network Integration Manages relationship with brokers, third-party administrators ("TPAs"), and other vendors to create uniquely tailored cost saving plans Solves the complexity issue for SMBs Pulls understanding of vendor needs and capabilities into a singular clear platform
Bundle Self-Funded Health Plan + Stop-Loss Insurance (1) About 12 days for employer groups of 10–100 employees & about 3 months for groups exceeding 100 employees (2) About 2 minutes for employer groups of 10–100 employees & about two weeks for groups exceeding 100 employees 8 Legacy Quoting Procedures Bindable Proposal Presented 4 Tiers 12 Plans Plan Design & Customization Underwriting & Risk Assessment Provider Network Integration ~2 minutes to 2 weeks(2) ~12 days to 3 months(1) Applications Package Creation Quotes Final Quote Nurse Review Bindable Proposal eDIYBS is a proprietary software offering which allows brokers to access bindable self- funded plan quotes in minutes Speed and ease of bindable quotes allow for enhanced plan flexibility and cost savings Workflow is trained via proprietary healthcare data vs public data sets
Nationwide Coverage Powered by HI Performance Network (1) All numbers as of June 30, 2026. (2) https://advancedbenefitconsulting.com/reference-based-pricing-key-to-solving-health-insurance-industry-cost-issues/ 50 States(1) 1.5M+ Provider Locations (1) 9 Nationwide reach with direct Medicare – based contracts across 50 states (1) Seamless integration with HIT's platform enables real-time claims and care coordination Medicare-based pricing drives 20%+ average cost savings vs. traditional commercial rates (2) Plan Design & Customization Underwriting & Risk Assessment Provider Network Integration
Health In Tech makes self-funded health insurance more accessible by integrating health plan administration and stop loss underwriting into one unified platform How HIT Makes Money Today (1) Based on size of business (2) Refer to the Company's 10-Q filing for the period ended June 30, 2026. Self-funded Stop Loss Insurance Program for Employers (12- or 36-month term) = Stop Loss Insurance + Self-funded Healthcare Plan Plan designs and vendor management for employers Monthly Administrative Fee(1) Recurring Revenue over policy terms of 12 or 36 months Underwriting for Carriers % of stop-loss gross premiums 10 ~16% of Revenue in Q2 2026(2) ~84% of Revenue in Q2 2026(2)
HIT By The Numbers (1) Contracted Revenue represents the total revenue expected to be generated over the contractual term of self-funded health plan policies placed through the Company's platform. (2) Pipeline Revenue represents revenue from self-funded plan policies that are being quoted, are in binding status, or have been contracted subsequent to the end of the reporting period. This metric reflects the entire contractual term of the underlying policies, some of which may not ultimately convert to revenue. (3) Platform Placed Plan Value represents the aggregate contractual value of self-funded health plans with stop-loss insurance (self-funded stop-loss plans) placed through the Company's platform during the fiscal year through the applicable fiscal quarter end, measured over each plan's full contractual term of typically 12 or 36 months from the plan's effective date. (4) Adjusted EBITDA represents our net income (loss) attributable to common stockholders before net interest expense, taxes and amortization expense, adjusted to eliminate stock-based compensation expense, including employer payroll taxes related to stock-based awards, provision for credit losses on other receivables and other non-recurring items. Adjusted EBITDA is not a measure calculated in accordance with United States Generally Accepted Accounting Principles, or GAAP. Please refer to Appendix Slide 22 of this presentation for a reconciliation of Adjusted EBITDA to net income (loss) attributable to common stockholders, the most comparable GAAP measurement, for the three months and six months ended June 30, 2025, and 2026. We exclude certain non-recurring or non-cash items when calculating Adjusted EBITDA. 11 As of June 30, 2026 38 States with Clients 396 Business Clients 933 Brokers, Agencies & TPAs $ $ $32.3M Contracted Revenue(1) $ $66.3M Pipeline Revenue(2) as of July 31, 2026 Revenue Adj. EBITDA(4) Q2 2026 $8.1M -14% YoY $(1.3)M n/a Q2 2025 $9.3M +86% YoY $1.6M +134% YoY FY 2025 $33.3M +71% YoY $4.1M +81% YoY Revenue Adj. EBITDA(4) 1H 2026 $16.8M -3% YoY $(2.6)M n/a 1H 2025 $17.3M +71% YoY $2.8M +146% YoY $ $ $ $84.0M Platform Placed Plan Value(3)
What Health In Tech is NOT A Risk-Bearing Insurer or Carrier (HIT does not hold any plan risk) An Entity with Underwriting Risk (eDIYBS generates quotes/binds; carriers & stop-loss providers bear the risk) Liable for Claims Outcomes (HIT has zero financial exposure) Exposed to Catastrophic Losses (Stone Mountain Risk models & delivers stop- loss protection; HIT enables only) HIT has NO Plan Risk Exposure Pure-opportunity model: Tech-enabled, fee-based, scalable upside with zero downside from claims or risk 12
HIT is Powering and Accelerating AI Disruption 13 The Health In Tech marketplace wins — AI accelerates value inside our platform, not outside of it HIT is a marketplace platform uniting an ecosystem of vendors HIT is the platform disruptors use to access the marketplace and deliver growth Distribution and marketplace capabilities insulate HIT from single-vendor AI disruption
More Data Monetizing proprietary data lake will enhance cross-selling opportunities and entry into new markets More Products Introducing novel new products such as Three-Year Rate Stabilization Program, HitRix, and others More Managing General Underwriters ("MGUs") & Carriers Driving MGUs onto the HIT platform to leverage AI-enabled underwriting feature Multiple Pathways to Drive Outsized Growth 14 More Brokers 1 2 3 4 HIT in-house sales team is focused on increasing awareness and driving broker count in 2026 and beyond
II Financials & Conclusion
Revenue and Forward Visibility (1) Contracted Revenue represents the total revenue expected to be generated over the contractual term of self-funded health plan policies placed through the Company's platform. (2) Pipeline Revenue represents revenue from self-funded plan policies that are being quoted, are in binding status, or have been contracted subsequent to the end of the reporting period. This metric reflects the entire contractual term of the underlying policies, some of which may not ultimately convert to revenue. Total Revenue ($ in millions) Historical + 2026 Guidance $19.5 2024 $33.3 2025 $45.0 $50.0 2026E +71% +35% to +50% 2026 revenue guidance reaffirmed at $45M–$50M Contracted Revenue1 ($ in millions) From 1H 2026 business activity, as of June 30, 2026 $32.3M $1.0M 2027 $14.0M 2H 2026 $17.3M 1H 2026 (Recognized) Pipeline Revenue2 ($ in millions) As of July 31, 2026 $66.3M $1.9M contracted post Q2 $64.4M in quoting or binding 16
Distribution Partner Growth 17 Brokers, Third-Party Administrators (TPAs), and Agencies 692 3/31/25 778 6/30/25 849 9/30/25 858 12/31/25 896 3/31/26 933 6/30/26 +19.9% Year-over-Year Growth 6/30/25 → 6/30/26 +155 Net New Partners Added in trailing 12 months +34.8% Growth Since Q1 2025 692 → 933 over five quarters
Conclusions Platform removes complexity and provides novel AI-powered products and solutions Operating in massive, underserved market based on legacy structures Proven business model poised to drive outsized growth No plan risk or underwriting risk exposure Highly aligned leadership team 18 Revenue Revenue ($M's) (1) CAGR is calculated from 2022 to the Mid-Point of Revenue Guidance of $47.5M (2) This is not a projection or guarantee of future results but rather is solely the guidance the Company reiterated in connection with its second quarter 2026 earnings release. The Company's actual results may vary significantly from this range. (2) (2)
III Appendix
Financial Results (1) Please refer to Appendix Slide 22 of this presentation for a reconciliation of Adjusted EBITDA to Net (loss) income attributable to common stockholders, the most comparable GAAP measurement, for the quarters and six months ended June 30, 2025, and 2026. 20 Three Months Ended 6/30 Six Months Ended 6/30 (In millions) 2025 2026 2025 2026 Total Revenue $9.3 $8.1 $17.3 $16.8 Gross Profit $6.3 $3.9 $11.7 $8.4 Gross Margin Percent 67.7% 48.7% 67.3% 50.1% Total Operating Expenses $5.6 $7.4 $10.5 $14.0 Net Income (Loss) $0.6 $(2.5) $1.1 $(4.1) Income (Loss) before income taxes $0.8 $(3.3) $1.5 $(5.4) Adjusted EBITDA (1) $1.6 $(1.3) $2.8 $(2.6)
Balance Sheet Highlights 21 Cash and Cash Equivalents ($ in millions) Working Capital ($ in millions) Stockholders' Equity ($ in millions) $8.1 $7.7 $6.5 6/30/25 12/31/25 6/30/26 $9.5 $11.0 $11.8 6/30/25 12/31/25 6/30/26 $16.4 $17.1 $19.6 6/30/25 12/31/25 6/30/26
GAAP To Non-GAAP Reconciliation – Adjusted EBITDA(1) 22 Three Months Ended June 30, Six Months Ended June 30, (in dollars) 2025 2026 2025 2026 Net income (loss) attributable to common stockholders 630,631 (2,511,024) 1,129,223 (4,099,305) Interest income (108,198) (69,568) (193,564) (137,039) Amortization expense 135,983 320,320 271,966 723,787 Income tax expense (benefit) 202,637 (809,888) 388,468 (1,289,957) Stock-based compensation expense, including employer payroll taxes related to stock-based awards 707,963 959,969 1,201,134 1,403,808 Provision for credit losses on other receivables - 739,773 - 739,773 Other non-recurring items - 37,341 - 37,341 Total net adjustments 938,385 1,177,947 1,668,004 1,477,713 Adjusted EBITDA 1,569,016 (1,333,077) 2,797,227 (2,621,592) (1) Adjusted EBITDA represents our net income (loss) attributable to common stockholders before net interest expense, taxes and amortization expense, adjusted to eliminate stock-based compensation expense, including employer payroll taxes related to stock-based awards, provision for credit losses on other receivables and other non-recurring items. Adjusted EBITDA is not a measure calculated in accordance with United States Generally Accepted Accounting Principles, or GAAP. We exclude certain non-recurring or non-cash items when calculating Adjusted EBITDA, and we believe this approach provides a more meaningful measure by offering a clearer view of our underlying operational performance.